This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Kyoto University, Osaka University. Active years: 2014-2017.
Company Filing History:
2 out of 868 
2 out of 1,041 
Years Active: 2014-2017
Title: Innovations of Yukimasa Taniguchi
Introduction
Yukimasa Taniguchi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of regenerative medicine through his innovative patents. With a total of 2 patents, Taniguchi's work focuses on enhancing cell culture techniques and improving the safety of human stem cells.
Latest Patents
Taniguchi's latest patents include "Modified laminin and use thereof" and "Culture substrate for human pluripotent stem cells and use thereof." The first patent provides a modified laminin that has a cell-growth regulatory molecule bound to specific sites on the laminin structure. This innovation allows for the culturing of human stem cells in a xeno-free environment, making them highly safe for applications in regenerative medicine. The second patent offers a culture substrate that enables the maintenance of human pluripotent stem cells in a pluripotent state without the need for feeder cells. By using specific laminin fragments, this substrate allows for the rapid expansion of stem cells.
Career Highlights
Taniguchi has worked with prestigious institutions such as Osaka University and Kyoto University. His research has significantly advanced the understanding and application of stem cell technology. His contributions have been instrumental in developing safer methods for stem cell culture.
Collaborations
Some of Taniguchi's notable coworkers include Kiyotoshi Sekiguchi and Sugiko Futaki. Their collaborative efforts have further enriched the research landscape in regenerative medicine.
Conclusion
Yukimasa Taniguchi's innovative work in the field of regenerative medicine has led to significant advancements in stem cell technology. His patents reflect a commitment to improving the safety and efficacy of cell culture methods. Taniguchi's contributions continue to influence the future of regenerative medicine.